Periodic paralysis: Understanding channelopathies
- 136 Downloads
Familial periodic paralyses are typical channelopathies (ie, caused by functional disturbances of ion channel proteins). The episodes of flaccid muscle weakness observed in these disorders are due to underexcitability of sarcolemma leading to a silent electromyogram and the lack of action potentials even upon electrical stimulation. Interictally, ion channel malfunction is well compensated, so that special exogenous or endogenous triggers are required to produce symptoms in the patients. An especially obvious trigger is the level of serum potassium (K+), the ion responsible for resting membrane potential and degree of excitability. The clinical symptoms can be caused by mutations in genes coding for ion channels that mediate different functions for maintaining the resting potential or propagating the action potential, the basis of excitability. The phenotype is determined by the type of functional defect brought about by the mutations, rather than the channel effected, because the contrary phenotypes hyperkalemic periodic paralysis (HyperPP) and hypokalemic periodic paralysis (HypoPP) may be caused by point mutations in the same gene. Still, the common mechanism for inexcitability in all known episodic-weakness phenotypes is a long-lasting depolarization that inactivates sodium ion (Na+) channels, initiating the action potential.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 3.Lehmann-Horn F, Jurkat-Rott K: Voltage-gated ion channels and hereditary disease. Physiol Rev 1999, 79:1317–1372. Introduction to the structure, function, isoforms, encoding genes, and pharmacology of voltage-gated ion channels followed by a description of most hereditary channelopathies in neurology, myology, nephrology, and cardiology; parallels in disease mechanisms are emphasized.PubMedGoogle Scholar
- 4.Lehmann-Horn F, Engel AG, Ricker K, Rüdel R: The periodic paralyses and paramyotonia congenita. In Myology, edn 2. Edited by Engel AG, Franzini-Armstrong C. New York: McGraw-Hill; 1994:1303–1334.Google Scholar
- 6.Cha A, Snyder GE, Selvin PR, Bezanilla F: Atomic scale movement of the voltage-sensing region in a potassium channel measured via spectroscopy. Nature 1999, 402:809–813. Distance changes measured by lanthanide-based resonance energy transfer suggest that the region associated with the S4 segment undergoes a rotation and possible tilt, rather than a large transmembrane movement, in response to voltage.PubMedCrossRefGoogle Scholar
- 13.Jurkat-Rott K, Mitrovic N, Hang C, et al.: Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci U S A 2000, 97:9549–9554. Identifies in five families not linked to the Ca2+ channel the skeletal muscle Na+ channel é subunit as being responsible for 1) the disease slowing and the smaller size of action potentials recorded intracellularly in native muscle fibers; and 2) Na+ current reduction and enhanced channel inactivation determined in an expression system are in agreement that HypoPP-2 represents the first Na+ channel disease caused by reduced function.PubMedCrossRefGoogle Scholar
- 14.Bendahhou S, Cummins TR, Griggs RC, et al.: Sodium channel inactivation defects are associated with acetazolamide-exacerbated hypokalemic periodic paralysis. Ann Neurol 2001, 50:417–420. A new HypoPP mutation is described that reacts contrarily to medication and shows the same functional defects of stabilization of the inactivated state.PubMedCrossRefGoogle Scholar
- 16.Ptécek LJ, George AL Jr, Griggs RC, et al.: Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 1991, 7:1021–1027.Google Scholar
- 20.Bendahhou S, Cummins TR, Tawil R, et al.: Activation and inactivation of the voltage-gated sodium channel: role of segment S5 revealed by a novel hyperkalaemic periodic paralysis mutation. J Neurosci 1999, 19:4762–4771. New structure-function relationships of the Na+ channel for the reader interested in electrophysiology.PubMedGoogle Scholar
- 24.Bendahhou S, Cummins TR, Hahn AF, et al.: A double mutation in families with periodic paralysis defines new aspects of sodium channel slow inactivation. J Clin Invest 2000, 106:431–438. Explains the mechanism of how defects of Na+ channel slow inactivation contributes to attacks of paralysis.PubMedGoogle Scholar
- 30.Tricarico D, Barbieri M, Conte-Camerino D: Acetazolamide opens the muscular KCa2+ channel: a novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis. Ann Neurol 2000, 48:304–312. Hypothesis of acetazolamide interaction with K+ channels that could explain depolarization and hypokalemia in hypokalemic periodic paralysis.PubMedCrossRefGoogle Scholar
- 35.Morrill JA, Cannon SC: Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L-Type Ca2+ channel expressed in Xenopus laevis oocytes. J Physiol 1999, 2:321–336. Heterologous expression of the skeletal muscle dihydropyridine receptor reveals reduced L-type current amplitude for all three mutations causing hypokalemic periodic paralysis similarly to previous reports; the IVS4 mutations slow current activation at depolarized membrane.CrossRefGoogle Scholar
- 38.Abbott GW, Butler MH, Bendahhou S, et al.: Mirp2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. Cell 2001, 104:217–231. Shows that the Shaw-like voltage-gated K+ channel Kv3.4 (_ subunit) and the b subunit MiRP2, the latter encoded by KCNE3, form a channel complex that sets the resting membrane potential of skeletal muscle. A kcne3 mutation predicting R83H was identified in two periodic paralysis families.PubMedCrossRefGoogle Scholar